PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises”

USPTO PatentsView assignee record - 14 granted patents across 6 technology areas, active 2016–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Explore the portfolio See the ranking
14
Total patents granted
6
CPC technology areas
11.6
Avg claims per patent
-100%
5-year filing velocity

The verdict

Obschestvo holds 14 US patents across 6 technology areas, rank #20,181 of 50,000 tracked assignees.

#20,181
of 50,000 US assignees by volume
Top 84%
by Innovation Score (25.0/100)
11.6
avg claims per patent
-100%
filing velocity, last 5 yrs

Portfolio overview

Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises” has been granted 14 US utility patents between 2016 and 2019, placing Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises” at rank #20,181 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.6 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises” is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 25.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 14 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises”'s 11.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises” against peers pursuing similar technology classes.

How does Obschestvo compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows Obschestvo holds 14 patents, placing it at rank #20,181 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Obschestvo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

25 Top 84% higher than 16% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). This entry sits in this band. 30–40: 15,294 US assignees (31%). Above this entry. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2019

02468 2016201720182019 3
USPTO utility patent grants by year · 2016–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises” patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 7.1%
2017 4 28.6%
2018 6 42.9%
2019 3 21.4%

Which technologies does Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises” patent most?

Top 6 of 6 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Velocity Declining

Where it ranks

Overall rank by patents

#20,181

Across all tracked assignees

Innovation Score

25.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises” hold?
Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises” holds 14 US granted patents filed between 2016 and 2019, spanning 6 technology areas.
What is Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises”'s Innovation Score?
Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises” has an Innovation Score of 25.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises” focus on?
Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises”'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 14 patents. The company has filed patents in 6 CPC subclasses total.
Is Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises”'s patent filing rate increasing or decreasing?
Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises”'s recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises”'s patents?
Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises”'s patents average 11.6 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises” patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

How to use this portfolio

Obschestvo's 14 grants land it in the top 84% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Obschestvo ranks #20,181 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

A61P technology

Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises”'s primary CPC class, all holders and yearly trends
Top 50 patent holders

See where Obschestvo S Ogranichennoi Otvetstvennostiyu “pharmenterprises” ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.